NCT00314262 2014-10-24
Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor
Emory University
Phase 1/2 Completed
Clinical Trials
4 trialsNCT00027976 2013-08-05
Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
University of Alabama at Birmingham
Phase 2/3 Withdrawn
NCT00101335 2013-07-11
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Fox Chase Cancer Center
Phase 2 Completed
NCT00036283 2008-09-29
Chemoprevention of Oral Premalignant Lesions
Pfizer
Phase 2 Completed